Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Single Center Trial
Latest Information Update: 18 Sep 2018
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 10 Sep 2018 Status changed from not yet recruiting to completed.
- 16 Mar 2013 New trial record